FDA Withdraws Draft Guidance on Premarket Notification Submissions for Automated Testing Instruments Used in Blood Establishments

Summary

The Food and Drug Administration (FDA) has withdrawn a draft guidance document issued on August 3, 2001, related to the review of premarket notification submissions for automated testing instruments used in blood establishments.